These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 31372851)
1. Validity of adopting a Health Assessment Questionnaire Disability Index less than 0.5 as a target in elderly rheumatoid arthritis patients. Yoshii I; Chijiwa T; Sawada N Clin Rheumatol; 2019 Dec; 38(12):3351-3360. PubMed ID: 31372851 [TBL] [Abstract][Full Text] [Related]
2. Influence of pain score measured by a visual analog scale (PS-VAS) on the Health Assessment Questionnaire Disability Index and 28-joint Disease Activity Index with C-reactive protein in rheumatoid arthritis patients. Yoshii I; Chijiwa T; Sawada N Int J Rheum Dis; 2018 Nov; 21(11):1955-1961. PubMed ID: 30175554 [TBL] [Abstract][Full Text] [Related]
3. Achieving simplified disease activity index remission in patients with active rheumatoid arthritis is associated with subsequent good functional and structural outcomes in a real-world clinical setting under a treat-to-target strategy. Hirano F; Yokoyama W; Yamazaki H; Amano K; Kawakami A; Hayashi T; Tamura N; Yasuda S; Dobashi H; Fujii T; Ito S; Kaneko Y; Matsui T; Okuda Y; Saito K; Suzuki F; Yoshimi R; Sakai R; Koike R; Kohsaka H; Miyasaka N; Harigai M; Mod Rheumatol; 2017 Sep; 27(5):811-819. PubMed ID: 27919205 [TBL] [Abstract][Full Text] [Related]
4. Long-term experience with etanercept in the treatment of rheumatoid arthritis in elderly and younger patients: patient-reported outcomes from multiple controlled and open-label extension studies. Schiff MH; Yu EB; Weinblatt ME; Moreland LW; Genovese MC; White B; Singh A; Chon Y; Woolley JM Drugs Aging; 2006; 23(2):167-78. PubMed ID: 16536638 [TBL] [Abstract][Full Text] [Related]
5. Rheumatoid arthritis patients with low baseline Health Assessment Questionnaire scores have a risk of functional disability progression: a post hoc analysis of a nationwide longitudinal cohort in Japan. Sumiyoshi R; Hidaka T; Koga T; Okada A; Fukuda T; Ishii T; Ueki Y; Kodera T; Nakashima M; Takahashi Y; Honda S; Horai Y; Watanabe R; Okuno H; Aramaki T; Izumiyama T; Takai O; Miyashita T; Kawashiri SY; Iwamoto N; Ichinose K; Tamai M; Nakamura H; Origuchi T; Eguchi K; Kawakami A; Clin Exp Rheumatol; 2020; 38(6):1096-1101. PubMed ID: 32896260 [TBL] [Abstract][Full Text] [Related]
6. Predictors of good response to conventional synthetic DMARDs in early seronegative rheumatoid arthritis: data from the ESPOIR cohort. Lukas C; Mary J; Debandt M; Daïen C; Morel J; Cantagrel A; Fautrel B; Combe B Arthritis Res Ther; 2019 Nov; 21(1):243. PubMed ID: 31730497 [TBL] [Abstract][Full Text] [Related]
7. Association of age with the non-achievement of clinical and functional remission in rheumatoid arthritis. Aoki T; Ito H; Ogura T; Hirata A; Nishiwaki Y; Kameda H Sci Rep; 2020 Sep; 10(1):15277. PubMed ID: 32943723 [TBL] [Abstract][Full Text] [Related]
8. Clinical Characteristics of Rheumatoid Arthritis Patients Achieving Functional Remission with Six Months of Biological DMARDs Treatment. Miwa Y; Takahashi R; Ikari Y; Maeoka A; Nishimi S; Oguro N; Hayashi T; Hatano M; Isojima S; Yanai R; Kasama T; Toyoshima Y; Inagaki K; Sanada K Intern Med; 2017; 56(8):903-906. PubMed ID: 28420837 [TBL] [Abstract][Full Text] [Related]
9. Sustained beneficial effects of a protocolized treat-to-target strategy in very early rheumatoid arthritis: three-year results of the Dutch Rheumatoid Arthritis Monitoring remission induction cohort. Vermeer M; Kuper HH; Moens HJ; Drossaers-Bakker KW; van der Bijl AE; van Riel PL; van de Laar MA Arthritis Care Res (Hoboken); 2013 Aug; 65(8):1219-26. PubMed ID: 23436821 [TBL] [Abstract][Full Text] [Related]
10. Predictive factors of 5-year health assessment questionnaire disability in early rheumatoid arthritis. Combe B; Cantagrel A; Goupille P; Bozonnat MC; Sibilia J; Eliaou JF; Meyer O; Sany J; Dubois A; Daurès JP; Dougados M J Rheumatol; 2003 Nov; 30(11):2344-9. PubMed ID: 14677175 [TBL] [Abstract][Full Text] [Related]
12. Clinical Characteristics of Rheumatoid Arthritis Patients Achieving Functional Remission after Six Months of Non-tumor Necrosis Factor Biological Disease-Modifying Antirheumatic Drugs (DMARDs) Treatment. Miwa Y; Saito M; Furuya H; Yanai R; Ikari Y; Hayashi T; Kasama T; Toyoshima Y; Inagaki K Intern Med; 2017 Sep; 56(17):2271-2275. PubMed ID: 28794381 [TBL] [Abstract][Full Text] [Related]
13. Factors Associated with Five-year Deterioration of the Health Assessment Questionnaire-Disability Index in Patients with Rheumatoid Arthritis: A Retrospective Cohort Study. Mochizuki T; Yano K; Ikari K; Okazaki K Intern Med; 2023 Jun; 62(12):1733-1737. PubMed ID: 36328576 [TBL] [Abstract][Full Text] [Related]
14. Functional disability in relation to radiological damage and disease activity in patients with rheumatoid arthritis in remission. Molenaar ET; Voskuyl AE; Dijkmans BA J Rheumatol; 2002 Feb; 29(2):267-70. PubMed ID: 11842821 [TBL] [Abstract][Full Text] [Related]
15. Muscle wasting, a neglected complication associated with physical dysfunction in elderly patients with rheumatoid arthritis: a cross-sectional observational study. Ma JD; Chen CT; Lin JZ; Li QH; Chen LF; Xu YH; Yang ZH; Zheng DH; Dai L Scand J Rheumatol; 2021 Jul; 50(4):280-289. PubMed ID: 33554691 [No Abstract] [Full Text] [Related]
16. Changes in Health Assessment Questionnaire disability scores over five years in patients with rheumatoid arthritis compared with the general population. Sokka T; Kautiainen H; Hannonen P; Pincus T Arthritis Rheum; 2006 Oct; 54(10):3113-8. PubMed ID: 17009231 [TBL] [Abstract][Full Text] [Related]
17. Aiming for SDAI remission versus low disease activity at 1 year after inclusion in ESPOIR cohort is associated with better 3-year structural outcomes. Ruyssen-Witrand A; Guernec G; Nigon D; Tobon G; Jamard B; Rat AC; Vittecoq O; Cantagrel A; Constantin A Ann Rheum Dis; 2015 Sep; 74(9):1676-83. PubMed ID: 24794151 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the Recent-Onset Arthritis Disability questionnaire with the Health Assessment Questionnaire disability index in patients with rheumatoid arthritis. Salaffi F; Ciapetti A; Gasparini S; Migliore A; Scarpellini M; Corsaro SM; Laganà B; Mozzani F; Varcasia G; Pusceddu M; Castriotta M; Serale F; Maier A; Foti R; Scarpa R; Bombardieri S; Clin Exp Rheumatol; 2010; 28(6):855-65. PubMed ID: 21122262 [TBL] [Abstract][Full Text] [Related]
19. Validation and reliability of the Timed Up and Go test for measuring objective functional impairment in patients with long-standing rheumatoid arthritis: a cross-sectional study. Kojima T; Ishikawa H; Tanaka S; Haga N; Nishida K; Yukioka M; Hashimoto J; Miyahara H; Niki Y; Kimura T; Oda H; Asai S; Funahashi K; Kojima M; Ishiguro N Int J Rheum Dis; 2018 Oct; 21(10):1793-1800. PubMed ID: 29210204 [TBL] [Abstract][Full Text] [Related]
20. Do radiographic joint damage and disease activity influence functional disability through different mechanisms? Direct and indirect effects of disease activity in established rheumatoid arthritis. Nair SC; Bijlsma JW; van der Werf JH; van der Veen MJ; Linn-Rasker SP; Vreugdenhil S; Lafeber FP; Welsing PM J Rheumatol; 2013 Sep; 40(9):1505-12. PubMed ID: 23818710 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]